Advertisement

© 2017

Neuropharmacology of New Psychoactive Substances (NPS)

The Science Behind the Headlines

  • Michael H. Baumann
  • Richard A. Glennon
  • Jenny L. Wiley
Book

Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 32)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Richard A. Glennon, Małgorzata Dukat
    Pages 19-47
  3. Michael H. Baumann, Mohammad O. Bukhari, Kurt R. Lehner, Sebastien Anizan, Kenner C. Rice, Marta Concheiro et al.
    Pages 93-117
  4. Mariana Angoa-Pérez, John H. Anneken, Donald M. Kuhn
    Pages 209-230
  5. Jenny L. Wiley, Julie A. Marusich, Brian F. Thomas
    Pages 231-248
  6. Esther Papaseit, José Moltó, Robert Muga, Marta Torrens, Rafael de la Torre, Magí Farré
    Pages 313-331
  7. Felix P. Mayer, Anton Luf, Constanze Nagy, Marion Holy, Rainer Schmid, Michael Freissmuth et al.
    Pages 333-350
  8. Fabrizio Schifano, Laura Orsolini, Duccio Papanti, John Corkery
    Pages 351-380

About this book

Introduction

Designer drugs, or new psychoactive substances (NPS), are synthetic chemicals that mimic the effects of classic drugs of abuse. There has been an alarming worldwide increase in the abuse of NPS in recent years. NPS are cheap, easy to obtain, and often legally available. In this volume, leading experts summarize the latest studies regarding the molecular mechanisms of action, behavioral effects, and adverse consequences of popular NPS. Specific chapters clarify the differences between various types of NPS, namely: stimulants, cannabinoids and hallucinogens. Thus, this volume broadens our understanding of NPS and provides insight into the rapidly evolving “new drug” phenomenon. 

Keywords

Behavior Cannabinoid Designer Drug Hallucinogen Receptor Stimulant Transporter

Editors and affiliations

  • Michael H. Baumann
    • 1
  • Richard A. Glennon
    • 2
  • Jenny L. Wiley
    • 3
  1. 1.Designer Drug Research Unit (DDRU)National Institute on Drug AbuseBaltimoreUSA
  2. 2.Department of Medicinal ChemistryVirginia Commonwealth UniversityRichmondUSA
  3. 3.RTI InternationalResearch Triangle ParkUSA

About the editors

 

Bibliographic information

  • Book Title Neuropharmacology of New Psychoactive Substances (NPS)
  • Book Subtitle The Science Behind the Headlines
  • Editors Michael H. Baumann
    Richard A. Glennon
    Jenny L. Wiley
  • Series Title Current Topics in Behavioral Neurosciences
  • Series Abbreviated Title Curr.Topics Behav.Neurosci.
  • DOI https://doi.org/10.1007/978-3-319-52444-3
  • Copyright Information Springer International Publishing AG (outside the USA) 2017
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences Biomedical and Life Sciences (R0)
  • Hardcover ISBN 978-3-319-52442-9
  • Softcover ISBN 978-3-319-84906-5
  • eBook ISBN 978-3-319-52444-3
  • Series ISSN 1866-3370
  • Series E-ISSN 1866-3389
  • Edition Number 1
  • Number of Pages VIII, 380
  • Number of Illustrations 68 b/w illustrations, 13 illustrations in colour
  • Topics Neurosciences
    Psychopharmacology
    Pharmacology/Toxicology
    Public Health
  • Buy this book on publisher's site
Industry Sectors
Biomedicine
Biotechnology
Health & Hospitals
Pharma

Reviews

 “This book brings together an international panel of leading experts to summarize the latest studies regarding the mechanisms of actions, behavioral effects, and adverse consequences of popular ‘designer drugs.’ … The book is intended to provide useful information to scientists, clinicians, law enforcement agencies, and policymakers who are engaged in the responding to the growing phenomenon of the use of these drugs.” (Michael Easton, Doody's Book Reviews, August, 2017)